Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

September 15, 2024

Study Completion Date

October 1, 2024

Conditions
Ultra-short-termIron Deficiency AnemiaScoliosis Idiopathic
Interventions
DRUG

Placebo

Patients of this group received placebo treatment consisted of two subcutaneous injections of 1 mL saline and an oral placebo

DRUG

ferric carboxymaltose , α erythropoietin, vitamin B12, oral folic acid

Patients of this group received Combination treatment consisted of a slow (30 min) intravenous infusion of 20 mg/kg ferric carboxymaltose (maximum of 1000 mg), 40 000 U subcutaneous α erythropoietin,1 mg subcutaneous vitamin B12(, and 5 mg oral folic acid (acidum folicum)

Trial Locations (1)

Unknown

tarek Abdel Lattif, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT04343170 - Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction | Biotech Hunter | Biotech Hunter